Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 71 results for "Myelodysplastic Syndromes (MDS)".

Thumbnail for Serum Ferritin as a Continuous Risk Factor for MACE and Leukemic Transformation in Myelodysplastic Neoplasms: A Restricted Cubic Spline Dose-Response Meta-Analysis and a Methodological Proof-of-Concept Study

MDS - 1556

Serum Ferritin as a Continuous Risk Factor for MACE and Leukemic Transformation in Myelodysplastic Neoplasms: A Restricted Cubic Spline Dose-Response Meta-Analysis and a Methodological Proof-of-Concept Study

Faiza Khalid

Poster Presenter: Faiza Khalid

Thumbnail for Divergent Global Trends in Myelodysplastic Neoplasms in the Survivorship Era: GBD 2023 Analysis of Rising Incidence, Disproportionate Mortality, and Widening Survival Gaps

MDS - 156

Divergent Global Trends in Myelodysplastic Neoplasms in the Survivorship Era: GBD 2023 Analysis of Rising Incidence, Disproportionate Mortality, and Widening Survival Gaps

Tapan Giri

Poster Presenter: Tapan Giri

Previous 1 2 3 4 5 6 7 8 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Mortality Trends and Demographic Disparities in Myelodysplastic Syndrome Among Adults Aged 15-54 Years in the United States, 1999 to 2024

MDS - 1616

Mortality Trends and Demographic Disparities in Myelodysplastic Syndrome Among Adults Aged 15-54 Years in the United States, 1999 to 2024

Fareed Baksh

Poster Presenter: Fareed Baksh

Thumbnail for Disease Context and Outcomes of Extracorporeal Membrane Oxygenation Among Adults With Hematologic Malignancies: A National ECMO Recipient Registry Analysis, 2016-2022

MDS - 1653

Disease Context and Outcomes of Extracorporeal Membrane Oxygenation Among Adults With Hematologic Malignancies: A National ECMO Recipient Registry Analysis, 2016-2022

Mariana Marrero Castillo

Poster Presenter: Mariana Marrero Castillo

Thumbnail for Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

MDS - 1661

Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

Uchenna Amaechi

Poster Presenter: Uchenna Amaechi

Thumbnail for Beyond Leukemic Transformation: Excess Cardiovascular Mortality in a Two-Decade SEER Cohort of 84,806 Patients with Myelodysplastic Syndromes

MDS - 1663

Beyond Leukemic Transformation: Excess Cardiovascular Mortality in a Two-Decade SEER Cohort of 84,806 Patients with Myelodysplastic Syndromes

Mishaal Munir

Poster Presenter: Mishaal Munir

Thumbnail for Risk of Progression to Acute Myeloid Leukemia Among Patients with Myelodysplastic Syndromes and Type 2 Diabetes Treated With GLP-1 Receptor Agonists

MDS - 1747

Risk of Progression to Acute Myeloid Leukemia Among Patients with Myelodysplastic Syndromes and Type 2 Diabetes Treated With GLP-1 Receptor Agonists

Jacqueline Nguyen

Poster Presenter: Jacqueline Nguyen

Thumbnail for A Simple Blood Marker for Predicting Luspatercept Response in Myelodyplastic Syndrome and Beta-Thalassemia

MDS - 202

A Simple Blood Marker for Predicting Luspatercept Response in Myelodyplastic Syndrome and Beta-Thalassemia

Adela-Sara Ionescu

Poster Presenter: Adela-Sara Ionescu

Thumbnail for Role of SGLT2 Inhibitor Use in Patients With Myelodysplastic Syndromes and Type 2 Diabetes: A TriNetX-Based Retrospective Analysis

MDS - 211

Role of SGLT2 Inhibitor Use in Patients With Myelodysplastic Syndromes and Type 2 Diabetes: A TriNetX-Based Retrospective Analysis

Ankit Kulkarni

Poster Presenter: Ankit Kulkarni

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors